CERO THERAPEUTICS, INC. CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • June 7th, 2023 • Phoenix Biotech Acquisition Corp. • Blank checks • Delaware
Contract Type FiledJune 7th, 2023 Company Industry JurisdictionThis Convertible Note Purchase Agreement (this “Agreement”) is made as of May [_], 2023 by and among Cero Therapeutics, Inc., a Delaware corporation (the “Company”), and the Holders listed on Schedule A hereto, each of which is herein referred to as an “Holder.”